Kepos Capital LP - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 856 filers reported holding BAXTER INTL INC in Q2 2024. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
Kepos Capital LP ownership history of BAXTER INTL INC
ValueSharesWeighting
Q2 2018$989,000
+13.5%
13,3940.0%0.05%
-2.0%
Q1 2018$871,00013,3940.05%
Other shareholders
BAXTER INTL INC shareholders Q2 2024
NameSharesValueWeighting ↓
Third Point 16,850,000$1,473,870,00017.51%
SECTOR GAMMA AS 472,305$41,313,0006.98%
TSFG, LLC 91,132$7,971,0006.10%
Veritas Asset Management LLP 6,386,849$558,658,0005.44%
Palmer Knight Co 64,636$5,654,0004.80%
Triodos Investment Management BV 193,700$16,943,0004.30%
Progressive Investment Management Corp 82,216$7,191,0003.85%
Alphinity Investment Management Pty Ltd 362,173$31,679,0003.65%
HealthCor Management, L.P. 1,032,820$90,341,0003.42%
Sivik Global Healthcare LLC 75,000$6,560,0003.31%
View complete list of BAXTER INTL INC shareholders